Arend RC, Monk BJ, Herzog TJ, Moore KN, et al. Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018)
for potential reduction of risk: A phase III, double blind, randomized controlled
trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with
platinum r Gynecol Oncol 2021 Feb 23. pii: S0090-8258(21)00151.
PMID: 33637348